XENE icon

Xenon Pharmaceuticals

206 hedge funds and large institutions have $2.58B invested in Xenon Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 68 increasing their positions, 73 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
206
Holders Change
-3
Holders Change %
-1.44%
% of All Funds
2.8%
Holding in Top 10
14
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+7.69%
% of All Funds
0.19%
New
20
Increased
68
Reduced
73
Closed
23
Calls
$14.8M
Puts
$6.93M
Net Calls
+$7.9M
Net Calls Change
+$3.62M
Name Holding Trade Value Shares
Change
Shares
Change %
TCM
26
TimesSquare Capital Management
New York
$25M -$3.47M -103,299 -12%
SL
27
Siren LLC
Connecticut
$24.6M -$369K -11,008 -1%
BNP Paribas Asset Management
28
BNP Paribas Asset Management
France
$23.6M +$1.35M +40,091 +6%
Citadel Advisors
29
Citadel Advisors
Florida
$23.1M +$12.1M +359,785 +110%
FTM
30
First Turn Management
California
$22.9M -$51.5K -1,535 -0.2%
Loomis, Sayles & Company
31
Loomis, Sayles & Company
Massachusetts
$22.6M -$474K -14,134 -2%
LGM
32
Logos Global Management
California
$21.8M +$21.8M +650,000 New
FLAM
33
First Light Asset Management
Minnesota
$21.1M -$17.9M -532,676 -46%
BCM
34
Boxer Capital Management
California
$20.1M
Fiera Capital (Canada)
35
Fiera Capital (Canada)
Quebec, Canada
$17.8M -$216K -6,445 -1%
Franklin Resources
36
Franklin Resources
California
$16.5M -$2.83M -84,470 -15%
CS
37
Candriam SCA
Luxembourg
$15.3M -$1.26M -37,531 -8%
Goldman Sachs
38
Goldman Sachs
New York
$14.9M +$1.09M +32,486 +8%
SVCM
39
Saturn V Capital Management
Texas
$13.9M +$3.06M +91,241 +28%
Aberdeen Group
40
Aberdeen Group
United Kingdom
$13.6M +$4.03M +120,255 +42%
Alyeska Investment Group
41
Alyeska Investment Group
Illinois
$12.3M +$2.63M +78,390 +27%
BBA
42
Baker Bros. Advisors
New York
$11.7M -$21.7M -646,271 -65%
Vanguard Group
43
Vanguard Group
Pennsylvania
$11.3M -$210K -6,265 -2%
PA
44
Perceptive Advisors
New York
$10.9M
State Street
45
State Street
Massachusetts
$10.3M +$567K +16,898 +6%
MB
46
MPM BioImpact
Massachusetts
$10.2M +$3.56M +106,186 +54%
Two Sigma Advisers
47
Two Sigma Advisers
New York
$10M +$3.36K +100 +0%
SC
48
Stempoint Capital
New York
$9.21M -$3.4M -101,212 -27%
DCM
49
DAFNA Capital Management
California
$9.18M
Balyasny Asset Management
50
Balyasny Asset Management
Illinois
$8.96M +$2.77M +82,562 +45%